Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...

Vaxxas Chair Sarah Meibusch said, "The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress ...

Poly(N-isopropylacrylamide) (PNIPAM) hydrogel undergoes significant but precise changes in size between 20 and 40 °C, making it an excellent candidate for use in variable-size deterministic lateral ...

An incorrect Funding statement was provided. The correct Funding statement reads: “The author(s) declare that financial support was received for the research and/or publication of this article. This ...

Abstract: The growing new field of cell microarrays enables new biomedical assays. We present a unique parallel cell printing technique, which allows the fast production of living cell microarrays. A ...

ABSTRACT: Herpes simplex virus (HSV), the viral agent causing human genital herpes, recurs easily and poses significant harm to patients, while also being associated with atherosclerosis (AS).

ABSTRACT: Herpes simplex virus (HSV), the viral agent causing human genital herpes, recurs easily and poses significant harm to patients, while also being associated with atherosclerosis (AS).

According to latest report, the global DNA and gene chip market size is calculated at USD 11.44 billion in 2024 and is projected to hit around USD 30.72 billion by 2033, expanding at a CAGR of 11.6% ...

Background and Purpose— Hypoxic–ischemic (HI) brain injury in newborn infants represents a major cause of cerebral palsy, development delay, and epilepsy. Stem cell-based therapy has the potential to ...